Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

12.79
Delayed Data
As of 4:00pm ET
 -0.14 / -1.08%
Today’s Change
8.31
Today|||52-Week Range
32.74
-11.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Operating ActivitiesNet Income / Starting Line-325.9M-1.2B-462.3M629.0M
 
 
 
 
 
Depreciation751.0M698.9M649.1M674.0M
 
 
 
 
 
Total Other Cash Flow174.7M1.3B262.4M-25.0M
 
 
 
 
 
Funds From Operations456.1M591.0M530.4M324.0M
 
 
 
 
 
Funds From/For Other Operating Expenses42.5M58.9M58.1M-592.0M
 
 
 
 
 
Net Cash Flow - Operating Activities413.6M532.1M472.4M916.0M
 
 
 
 
 
 
InvestingIncrease In Investments-1.4M21.2K431.2K0.00
 
 
 
 
Decrease In Investments15.7M1.1M95.8K0.00
 
 
 
 
Capital Expenditures-70.1M-51.8M-50.8M-38.0M
 
 
 
 
 
Fixed Asset Disposal108.7M18.7M63.9M1.3B
 
 
 
 
 
Net Assets From Acquisitions -1.6M736.1K30.7M-9.0M
 
 
 
 
 
Other Investing - Uses0.000.00-29.8M0.00
 
 
Net Cash Flow Investing47.9M-69.6M9.5M1.1B
 
 
 
 
 
 
FinancingShort Term Borrowings309.7K-411.4K3.1M-1.0M
 
 
 
 
 
Long Term Borrowings39.4M-18.5M-20.9M6.2B
 
 
 
 
 
Long Term Debt Reduction-888.7M-635.8M-488.9M-7.6B
 
 
 
 
 
Net Proceeds Stock Sale-77.4K32.9M-669.6K0.00
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing----------
Other Uses - Financing57.9M44.9M39.7M9.0M
 
 
 
 
 
Net Cash Flow - Financing-906.9M-666.8M-538.7M-1.4B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-4.4M3.1M-60.1M8.0M
 
 
 
 
 
 
Net Change In Cash-445.4M-204.2M-56.7M660.0M